D32E (p.Asp32Glu) variant of SOST (Sclerostin)

D32E (p.Asp32Glu) in SOST (Sclerostin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.47 / 1. The record also includes population frequency data and structural context.

D32E (p.Asp32Glu) variant details